Health ❯ Healthcare ❯ Immunotherapy

Cancer Treatment

Clinical Trials PD-1 Inhibitors Research Innovations Targeted Therapies Immune System Interaction Intratumoral Interactions Vaccine Development Patient-Specific Approaches Targeted Therapy Antibody Development Bowel Cancer Vaccines Tissue-Resident Memory T Cells Non-Hodgkin Lymphoma Patient Experience

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Early 2026 momentum reflects surging Anktiva revenue alongside Saudi clearance opening a new market.

Study Pinpoints GPR25 as Switch for Tissue-Resident Memory T Cell Formation

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing